HIV Prevention Methods
HIV Prevention Methods
HIV Prevention Methods
Body fluids that pose a risk for HIV ( blood, bloodstained saliva,
breast milk, genital secretions, CSF, amniotic, rectal, peritoneal,
synovial, pericardial or pleural fluids)
Regimen A regimen with 2 ARV drugs is effective, but 3 drugs are preferred
(3TC/FTC + Raltegravir or Dolutegravir)
Blood tests Initial then repeat HIV test 30d and 90d
PrEP HIV Pre Exposure Prophylaxis
Eligibility HIV negative; No suspicion of acute HIV infection
Willingness to use PrEP as prescribed, periodic HIV testing
PrEP is recommended for anyone with: (Substantial risk of HIV infection) eg
• Condomless vaginal or anal sex with a partner of unknown HIV status
• HIV-positive sex partner (especially if partner's HIV viral load is detectable or unknown)
• A recent bacterial sexually transmitted infection (STI) (gonorrhoea/chlamydia/syphilis);
Injection drug use with sharing of needles/equipment
• Any survival/transactional sex
• Desire to conceive with a partner who is HIV-positive
On-Demand or 2-1-1 Oral PrEP: Alternative for men who have sex with men (MSM) who
have sex infrequently
Injection PrEP: Cabotegravir (CAB) 600 mg IM (gluteal muscle) - initial dose, 2nd dose 1
month after 1st dose, then every 2 months
U=U (TasP)
• Clinical studies have shown that using effective
antiretroviral therapy (ART) to consistently suppress
plasma HIV RNA levels to <200 copies/mL prevents
transmission of HIV to sexual partners.